DEXCOM INC (DC4.DE) Stock Fundamental Analysis
Europe - FRA:DC4 - US2521311074 - Common Stock
61.38 EUR
+0.63 (+1.04%)
Taking everything into account, DC4 scores 6 out of 10 in our fundamental rating. DC4 was compared to 59 industry peers in the Health Care Equipment & Supplies industry. DC4 scores excellent on profitability, but there are some minor concerns on its financial health. DC4 is valued quite expensive, but it does show an excellent growth. These ratings would make DC4 suitable for growth investing!
1. Profitability
1.1 Basic Checks
DC4 had positive earnings in the past year.
In the past year DC4 had a positive cash flow from operations.
DC4 had positive earnings in each of the past 5 years.
Each year in the past 5 years DC4 had a positive operating cash flow.
1.2 Ratios
DC4's Return On Assets of 7.80% is fine compared to the rest of the industry. DC4 outperforms 79.66% of its industry peers.
With an excellent Return On Equity value of 22.21%, DC4 belongs to the best of the industry, outperforming 91.53% of the companies in the same industry.
DC4's Return On Invested Capital of 14.52% is amongst the best of the industry. DC4 outperforms 94.92% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DC4 is above the industry average of 9.04%.
The last Return On Invested Capital (14.52%) for DC4 is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROIC | 14.52% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
Looking at the Profit Margin, with a value of 13.29%, DC4 is in the better half of the industry, outperforming 76.27% of the companies in the same industry.
In the last couple of years the Profit Margin of DC4 has grown nicely.
DC4 has a better Operating Margin (17.22%) than 76.27% of its industry peers.
In the last couple of years the Operating Margin of DC4 has grown nicely.
DC4 has a Gross Margin of 60.01%. This is comparable to the rest of the industry: DC4 outperforms 55.93% of its industry peers.
In the last couple of years the Gross Margin of DC4 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DC4 is creating value.
DC4 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DC4 has more shares outstanding
The debt/assets ratio for DC4 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.05 indicates that DC4 is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.05, DC4 belongs to the top of the industry, outperforming 83.05% of the companies in the same industry.
DC4 has a debt to FCF ratio of 4.38. This is a neutral value as DC4 would need 4.38 years to pay back of all of its debts.
DC4 has a better Debt to FCF ratio (4.38) than 61.02% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that DC4 is somewhat dependend on debt financing.
The Debt to Equity ratio of DC4 (0.50) is worse than 61.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Altman-Z | 5.05 |
ROIC/WACC1.84
WACC7.88%
2.3 Liquidity
DC4 has a Current Ratio of 1.52. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
DC4 has a Current ratio of 1.52. This is comparable to the rest of the industry: DC4 outperforms 47.46% of its industry peers.
DC4 has a Quick Ratio of 1.35. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
DC4 has a Quick ratio of 1.35. This is in the better half of the industry: DC4 outperforms 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
DC4 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.86%.
Measured over the past years, DC4 shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
DC4 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
3.2 Future
Based on estimates for the next years, DC4 will show a very strong growth in Earnings Per Share. The EPS will grow by 22.60% on average per year.
DC4 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.90% yearly.
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 41.76 indicates a quite expensive valuation of DC4.
Compared to the rest of the industry, the Price/Earnings ratio of DC4 is on the same level as its industry peers.
DC4's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.91.
The Price/Forward Earnings ratio is 27.08, which means the current valuation is very expensive for DC4.
DC4's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.92. DC4 is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.76 | ||
| Fwd PE | 27.08 |
4.2 Price Multiples
DC4's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DC4 is more expensive than 62.71% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DC4 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.89 | ||
| EV/EBITDA | 26.02 |
4.3 Compensation for Growth
DC4's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DC4 may justify a higher PE ratio.
DC4's earnings are expected to grow with 24.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)1.43
EPS Next 2Y26.2%
EPS Next 3Y24.65%
5. Dividend
5.1 Amount
DC4 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:DC4 (10/24/2025, 7:00:00 PM)
61.38
+0.63 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap24.07B
Revenue(TTM)4.30B
Net Income(TTM)571.50M
Analysts84.57
Price Target89.5 (45.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-4.09%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-1.87%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)9.43%
EPS beat(12)10
Avg EPS beat(12)14.38%
EPS beat(16)11
Avg EPS beat(16)8.49%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)0.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)5
Avg Revenue beat(12)-0.39%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)0%
PT rev (3m)0.76%
EPS NQ rev (1m)0.42%
EPS NQ rev (3m)0.28%
EPS NY rev (1m)0.14%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.76 | ||
| Fwd PE | 27.08 | ||
| P/S | 6.49 | ||
| P/FCF | 48.89 | ||
| P/OCF | 28.25 | ||
| P/B | 10.84 | ||
| P/tB | 11.34 | ||
| EV/EBITDA | 26.02 |
EPS(TTM)1.47
EY2.39%
EPS(NY)2.27
Fwd EY3.69%
FCF(TTM)1.26
FCFY2.05%
OCF(TTM)2.17
OCFY3.54%
SpS9.46
BVpS5.66
TBVpS5.41
PEG (NY)1.56
PEG (5Y)1.43
Graham Number13.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROCE | 18.43% | ||
| ROIC | 14.52% | ||
| ROICexc | 53.56% | ||
| ROICexgc | 59.66% | ||
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% | ||
| FCFM | 13.27% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 9.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.12% | ||
| Profit Quality | 99.88% | ||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 5.05 |
F-Score6
WACC7.88%
ROIC/WACC1.84
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
EBIT growth 1Y6.1%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.4%
FCF growth 1Y22.49%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y28.04%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DC4.DE FAQ
What is the ChartMill fundamental rating of DEXCOM INC (DC4.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to DC4.DE.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 3 / 10 to DEXCOM INC (DC4.DE). This can be considered as Overvalued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DC4.DE) has a profitability rating of 8 / 10.
What is the earnings growth outlook for DEXCOM INC?
The Earnings per Share (EPS) of DEXCOM INC (DC4.DE) is expected to grow by 26.84% in the next year.